Edition:
India

Consun Pharmaceutical Group Ltd (1681.HK)

1681.HK on Hong Kong Stock

4.87HKD
8:57am IST
Change (% chg)

HK$0.11 (+2.31%)
Prev Close
HK$4.76
Open
HK$4.79
Day's High
HK$4.95
Day's Low
HK$4.79
Volume
388,000
Avg. Vol
1,332,484
52-wk High
HK$7.58
52-wk Low
HK$4.18

Latest Key Developments (Source: Significant Developments)

Consun Pharmaceutical Group Gets Drug Registration Approvals Of "Iopamidol Injection"
Monday, 15 Jul 2019 

July 15 (Reuters) - Consun Pharmaceutical Group Ltd <1681.HK>::DRUG REGISTRATION APPROVALS OF "IOPAMIDOL INJECTION" GRANTED BY NATIONAL MEDICAL PRODUCTS ADMINISTRATION.  Full Article

Consun Pharmaceutical Group Updates On Progress In Application For New Medicine Registration
Thursday, 15 Mar 2018 

March 15 (Reuters) - Consun Pharmaceutical Group Ltd <1681.HK>::UNITS ‍GRANTED "CLINICAL TRIAL APPROVAL" BY CHINA FDA FOR "ASTRAGALI POWDER PELLET", A PIPELINE MEDICINE​.  Full Article

Far East Horizon's unit subscribes for 43.6 mln placing shares of Consun Pharmaceutical Group
Wednesday, 25 Oct 2017 

Oct 25 (Reuters) - Far East Horizon Ltd <3360.HK>::Unit subscribes for 43.6 million placing shares of Consun Pharmaceutical Group at HK$6.60 per placing share​.  Full Article

Consun Pharmaceutical considering spin-off and listing of Guangxi Yulin Pharmaceutical Group
Thursday, 19 Oct 2017 

Oct 19 (Reuters) - Consun Pharmaceutical Group Ltd <1681.HK>:Board considering spin-off and listing of Guangxi Yulin Pharmaceutical Group and its subsidiaries​.  Full Article

Consun Pharmaceutical Group posts ‍HY profit attributable RMB184.8 million
Thursday, 24 Aug 2017 

Aug 24 (Reuters) - Consun Pharmaceutical Group Ltd <1681.HK>:Board declared payment of an interim dividend of HKD0.096 per share for six months ended 30 june 2017..‍HY profit attributable RMB184.8 million an increase of 27.1%​.Board has declared payment of an interim dividend of HKD0.096 per share.Revenue for HY amounted to RMB769.4 million, up 70.3%.  Full Article